Phage size does Matter…

It represents the maximum potential capacity of the insertion length (bp).  Small phage particle cannot afford the over-size DNA cloning.  

 

1. Vincogen USA is the only Bio-Pharmaceuticals to develop a novel, patented Vinco-T4 technology for ORAL/inhale drug system that is being used to generate drugs/ antibodies and engineered proteins for the purpose of creating protein based pharmaceuticals and Personalized Medicine.  We apply our proprietary Vinco-T4 technology to produce the next generation of drugs/vaccines for the prevention and treatment of our target diseases and Personalized Medicine.
   

   Advantages:

   • * Vinco-T4 dual  provides ability for two specific antigen/targets (combination therapy)
   • * Immunity has been demonstrated in cellular or animal model
   • * Oral and Inhalation administration
   • * No viruses used in production 
   • * No chicken egg-related materials
   • * No additives (e.g. antibiotics or preservatives)
   • * No Adjuvant formulation